methoxyflurane उदाहरण वाक्य
उदाहरण वाक्य
- With a minimum alveolar concentration ( MAC ) of 0.16 %, methoxyflurane is an extremely potent anesthetic agent.
- Miller and his team continued to develop organofluorine chemistry after the end of World War II and methoxyflurane was synthesized in 1948.
- As of 2010, methoxyflurane was listed under the Australian Pharmaceutical Benefits Scheme for the initial management of pain due to acute patient transport.
- A study published in 1973 by Cousins and Mazze demonstrated that compared with halothane, methoxyflurane produces dose-dependent and deleterious abnormalities in renal function.
- In 1968, Robert Wexler of Abbott Laboratories developed the Analgizer, a disposable inhaler that allowed the self-administration of methoxyflurane vapor in air for analgesia.
- The concurrent formation of inorganic fluoride and DCAA is unique to methoxyflurane biotransformation compared with other volatile anesthetics, and this combination is more toxic than fluoride alone.
- Because of its low volatility and very high boiling point ( 104.8 �C at 1 atmosphere ), methoxyflurane has a low vapor pressure at anesthetic vaporizers.
- This may explain why fluoride formation from methoxyflurane is associated with nephrotoxicity, while fluoride formation from other volatile anesthetics ( such as enflurane and sevoflurane ) is not.
- The obsolete ( as an anaesthetic ) agent methoxyflurane had a nephrotoxic effect and caused acute renal failure, usually attributed to the liberation of fluoride ions from its metabolism.
- The Analgizer inhaler was withdrawn in 1974, but use of methoxyflurane as a sedative and analgesic continues in Australia and New Zealand in the form of the Penthrox inhaler.